Korean Medication Algorithm Project for Bipolar Disorder: third revision

References

• No authors listedTreatment of bipolar disorder. The Expert Consensus Panel for Bipolar DisorderJ Clin Psychiatry199657Suppl 12A388
   Google Scholar
• SachsGSPrintzDJKahnDACarpenterDDochertyJPThe Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000Postgrad Med2000Spec No110410895797
   PubMedGoogle Scholar
• American Psychiatric AssociationPractice guideline for the treatment of patients with bipolar disorder (revision)Am J Psychiatry20021594 Suppl150
   Web of Science ®Google Scholar
• GrunzeHVietaEGoodwinGMThe World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorderWorld J Biol Psychiatry201314315421923480132
   PubMed Web of Science ®Google Scholar
• GrunzeHVietaEGoodwinGMThe World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depressionWorld J Biol Psychiatry20101128110920148751
   PubMed Web of Science ®Google Scholar
• GrunzeHVietaEGoodwinGMThe World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute maniaWorld J Biol Psychiatry20091028511619347775
   PubMed Web of Science ®Google Scholar
• GrunzeHKasperSGoodwinGBowdenCMöllerHJWFSBP Task Force on Treatment Guidelines for Bipolar DisordersThe World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatmentWorld J Biol Psychiatry20045312013515346536
   PubMed Web of Science ®Google Scholar
• GrunzeHKasperSGoodwinGThe World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of ManiaWorld J Biol Psychiatry20034151312582971
   PubMed Web of Science ®Google Scholar
• GrunzeHKasperSGoodwinGWorld Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depressionWorld J Biol Psychiatry20023311512412478876
   PubMedGoogle Scholar
• GoodwinGMConsensus Group of the British Association for PsychopharmacologyEvidence-based guidelines for treating bipolar disorder: recommendations from the British Association for PsychopharmacologyJ Psychopharmacol2003172149173 discussion 14712870562
   PubMed Web of Science ®Google Scholar
• GoodwinGMConsensus Group of the British Association for PsychopharmacologyEvidence-based guidelines for treating bipolar disorder: revised second edition – recommendations from the British Association for PsychopharmacologyJ Psychopharmacol200923434638819329543
   PubMed Web of Science ®Google Scholar
• YathamLNKennedySHParikhSVCanadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013Bipolar Disord201315114423237061
   PubMed Web of Science ®Google Scholar
• YathamLNKennedySHSchafferACanadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009Bipolar Disord200911322525519419382
   PubMed Web of Science ®Google Scholar
• YathamLNKennedySHO’DonovanCCanadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007Bipolar Disord20068672173917156158
   PubMed Web of Science ®Google Scholar
• YathamLNKennedySHO’DonovanCCanadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversiesBipolar Disord20057Suppl 356915952957
   PubMed Web of Science ®Google Scholar
• BahkWMShinYCJonDIKorean Medication Algorithm for Bipolar Disorder (I)Korean J Psychopharmacol200213205221
   Google Scholar
• KimCHMinKJShinYCFeasibility of Korean Medication Algorithm for Bipolar Disorder (I): Global assessmentKorean J Psychopharmacol200516225233
   Google Scholar
• ShinYCBahkWMKimCHFeasibility of Korean Medication Algorithm for Bipolar Disorder (II): Choice of medicationsKorean J Psychopharmacol200516285291
   Google Scholar
• JonDIBahkWMShinYCFeasibility of Korean Medication Algorithm for Bipolar Disorder (III): Treatment response and tolerabilityKorean J Psychopharmacol200516292300
   Google Scholar
• JonDIBahkWMYoonBHRevised Korean medication algorithm for bipolar disorderWorld J Biol Psychiatry2009104 Pt 384685518615367
   PubMed Web of Science ®Google Scholar
• ShinYCMinKJYoonBHKorean medication algorithm for bipolar disorder: second revisionAsia Pac Psychiatry20135430130823857877
   PubMed Web of Science ®Google Scholar
• Seok SeoJRim SongHBin LeeHThe Korean Medication Algorithm for Depressive Disorder: second revisionJ Affect Disord201416731232125010375
   PubMed Web of Science ®Google Scholar
• SmithLACorneliusVWarnockATacchiMJTaylorDAcute bipolar mania: a systematic review and meta-analysis of co-therapy vs monotherapyActa Psychiatr Scand20071151122017201861
   PubMed Web of Science ®Google Scholar
• LeeSMShimIHWooYSJunTYBahkWMA trend of medication prescription pattern for outpatients with bipolar disorder in a university hospital: focusing on atypical antipsychoticsKorean J Psychopharmacol2014253124133 Korean
   Google Scholar
• ChaJMShimIHWooYSJunTYBahkWMA trend of drug use in inpatients with bipolar disorder: comparing 2009–2012 with 1998–2001 in one university hospitalKorean J Psychopharmacol2014253114123
   Google Scholar
• TohenMVietaECalabreseJEfficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depressionArch Gen Psychiatry200360111079108814609883
   PubMed Web of Science ®Google Scholar
• CalabreseJRKeckPEJrMacfaddenWA randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depressionAm J Psychiatry200516271351136015994719
   PubMed Web of Science ®Google Scholar
• ThaseMEMacfaddenWWeislerRHEfficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study)J Clin Psychopharmacol200626660060917110817
   PubMed Web of Science ®Google Scholar
• McElroySLWeislerRHChangWA double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II)J Clin Psychiatry201071216317420122366
   PubMed Web of Science ®Google Scholar
• CruzNSanchez-MorenoJTorresFGoikoleaJMValentiMVietaEEfficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysisInt J Neuropsychopharmacol201013151419638254
   PubMed Web of Science ®Google Scholar
• SelleVSchalkwijkSVázquezGHBaldessariniRJTreatments for acute bipolar depression: meta-analyses of placebo-controlled, monotherapy trials of anticonvulsants, lithium and antipsychoticsPharmacopsychiatry2014472435224549862
   PubMed Web of Science ®Google Scholar
• FountoulakisKNVietaESchmidtFAripiprazole monotherapy in the treatment of bipolar disorder: a meta-analysisJ Affect Disord2011133336137021040979
   PubMed Web of Science ®Google Scholar
• VietaEValentiMPharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxisCNS Drugs201327751552923749421
   PubMed Web of Science ®Google Scholar
• McIntyreRSChaDSKimRDMansurRBA review of FDA-approved treatment options in bipolar depressionCNS Spectr201318Suppl 1420 ; quiz 2124237641
   PubMed Web of Science ®Google Scholar
• GaoKKempDEFeinENumber needed to treat to harm for discontinuation due to adverse events in the treatment of bipolar depression, major depressive disorder, and generalized anxiety disorder with atypical antipsychoticsJ Clin Psychiatry20117281063107121034695
   PubMed Web of Science ®Google Scholar
• De FruytJDeschepperEAudenaertKSecond generation antipsychotics in the treatment of bipolar depression: a systematic review and meta-analysisJ Psychopharmacol201226560361721940761
   PubMed Web of Science ®Google Scholar
• QuanteAZeugmannSLuborzewskiAAripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot studyHum Psychopharmacol201025212613220196183
   PubMed Web of Science ®Google Scholar
• MazzaMSquillaciotiMRPecoraRDJaniriLBriaPBeneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trialExpert Opin Pharmacother20089183145314919040335
   PubMed Web of Science ®Google Scholar
• DunnRTStanVAChrikiLSFilkowskiMMGhaemiSNA prospective, open-label study of Aripiprazole mono- and adjunctive treatment in acute bipolar depressionJ Affect Disord20081101–2707418272230
   PubMed Web of Science ®Google Scholar
• GeddesJRCalabreseJRGoodwinGMLamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trialsBr J Psychiatry200919414919118318
   PubMed Web of Science ®Google Scholar
• VietaEValentiMMixed states in DSM-5: implications for clinical care, education, and researchJ Affect Disord20131481283623561484
   PubMed Web of Science ®Google Scholar
• YildizAVietaETohenMBaldessariniRJFactors modifying drug and placebo responses in randomized trials for bipolar maniaInt J Neuropsychopharmacol201114786387521299919
   PubMed Web of Science ®Google Scholar
• González-PintoAAldamaAMosqueraFGonzález GómezCEpidemiology, diagnosis and management of mixed maniaCNS Drugs200721861162617630815
   PubMed Web of Science ®Google Scholar
• FountoulakisKNKontisDGondaXYathamLNA systematic review of the evidence on the treatment of rapid cycling bipolar disorderBipolar Disord201315211513723437958
   PubMed Web of Science ®Google Scholar
• BaldessariniRJHennenJWilsonMOlanzapine versus placebo in acute mania: treatment responses in subgroupsJ Clin Psychopharmacol200323437037612920413
   PubMed Web of Science ®Google Scholar
• VietaECalabreseJRHennenJComparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine: analysis of pooled dataJ Clin Psychiatry200465101420142815491248
   PubMed Web of Science ®Google Scholar
• ShiLSchuhLMTrzepaczPTHuangLXNamjoshiMATohenMImprovement of Positive and Negative Syndrome Scale cognitive score associated with olanzapine treatment of acute maniaCurr Med Res Opin20042091371137615383185
   PubMed Web of Science ®Google Scholar
• SuppesTDattoCMinkwitzMNordenhemAWalkerCDarkoDEffectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depressionJ Affect Disord20101211–210611519903574
   PubMed Web of Science ®Google Scholar
• SuppesTEudiconeJMcQuadeRPikalovA3rdCarlsonBEfficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorderJ Affect Disord20081071–314515417904226
   PubMed Web of Science ®Google Scholar
• VietaECalabreseJRGoikoleaJMRainesSMacfaddenWBOLDER Study GroupQuetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled studyBipolar Disord20079441342517547587
   PubMed Web of Science ®Google Scholar
• MuzinaDJMomahCEudiconeJMAripiprazole monotherapy in patients with rapid-cycling bipolar I disorder: an analysis from a long-term, double-blind, placebo-controlled studyInt J Clin Pract200862567968718373615
   PubMed Web of Science ®Google Scholar
• WooYSBahkWMPaeCUObservational study to evaluate the clinical benefit of lamotrigine add-on therapy in bipolar patients in a naturalistic treatment settingAsia Pac Psychiatry20146333434124038834
   PubMed Web of Science ®Google Scholar
• WooYSBahkWMJonDIRash in adult patients receiving lamotrigine to treat bipolar I disorder in Korea: a multicenter, prospective, naturalistic, open-label trialProg Neuropsychopharmacol Biol Psychiatry20093371147115219540298
   PubMed Web of Science ®Google Scholar
• McIntyreRSAripiprazole for the maintenance treatment of bipolar I disorder: A reviewClin Ther201032Suppl 1S32S3820152551
   PubMed Web of Science ®Google Scholar
• KempDEKarayalONCalabreseJRZiprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: long-term changes in weight and metabolic profilesEur Neuropsychopharmacol201222212313121798721
   PubMed Web of Science ®Google Scholar
• SachsGSIceKSChappellPBEfficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trialJ Clin Psychiatry201172101413142221672493
   PubMed Web of Science ®Google Scholar
• WarringtonLLombardoILoebelAIceKZiprasidone for the treatment of acute manic or mixed episodes associated with bipolar disorderCNS Drugs2007211083584917850172
   PubMed Web of Science ®Google Scholar
• WeislerRWarringtonLDunnJAdjunctive ziprasidone in bipolar mania: Short- and long-term dataBiol Psychiatry20045543s43s
   Web of Science ®Google Scholar
• KowatchRAFristadMBirmaherBTreatment guidelines for children and adolescents with bipolar disorderJ Am Acad Child Adolesc Psychiatry200544321323515725966
   PubMed Web of Science ®Google Scholar
• McClellanJKowatchRFindlingRLWork Group on Quality IssuesPractice parameter for the assessment and treatment of children and adolescents with bipolar disorderJ Am Acad Child Adolesc Psychiatry200746110712517195735
   PubMed Web of Science ®Google Scholar
• FindlingRLNyilasMForbesRAAcute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled studyJ Clin Psychiatry200970101441145119906348
   PubMed Web of Science ®Google Scholar
• HaasMDelbelloMPPandinaGRisperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled studyBipolar Disord200911768770019839994
   PubMed Web of Science ®Google Scholar
• PathakSFindlingRLEarleyWRAcevedoLDStankowskiJDelbelloMPEfficacy and safety of quetiapine in children and adolescents with mania associated with bipolar I disorder: a 3-week, double-blind, placebo-controlled trialJ Clin Psychiatry2013741e100e10923419231
   PubMed Web of Science ®Google Scholar
• MillerLBarnettSMood lability and bipolar disorder in children and adolescentsInt Rev Psychiatry200820217117618386208
   PubMed Web of Science ®Google Scholar
• WooYSWangHRBahkWMLurasidone as a potential therapy for bipolar disorderNeuropsychiatr Dis Treat201391521152924143101
   PubMed Web of Science ®Google Scholar